Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
Court temporarily stays judge's order for Border Patrol commander to appear daily in court over use-of-force allegations during immigration raids.
Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
Court temporarily stays judge's order for Border Patrol commander to appear daily in court over use-of-force allegations during immigration raids.